MyFinsight
Home
About
Contact
cvkd: the income statement
Download
Download image
Interest and dividend
income
$48,098
Net loss and
comprehensive loss
-$2,685,705
Total other income
$48,098
Loss from operations
-$2,733,803
Total operating
expenses
$2,733,803
Depreciation expense
$401
Research and development
expenses
$688,465
General and
administrative expenses
$2,044,937
Back
Back
Income Statement
source: myfinsight.com
Cadrenal Therapeutics, Inc. (CVKD)
Cadrenal Therapeutics, Inc. (CVKD)